By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
Home
Home
News
News

Venture Kick Stage 3 completed with CHF 150k secured

Fundraising

Dexterous Endoscopes has been awarded a total of CHF 150k through the Venture Kick program, successfully completing all three stages.

This milestone marks a strong validation from one of Switzerland’s leading startup support programs, which backs high-potential ventures through a highly competitive, multi-stage selection process. Reaching Stage 3 highlights both the technological strength and commercial potential of the project.

The funding will support continued development, preclinical validation, and preparation for the next phase of growth, including upcoming fundraising and regulatory steps toward market entry.

Learn more:
https://www.venturekick.ch/Dexterous-Endoscopes-receives-CHF-150000-from-Venture-Kick-to-create-nextgeneration-endoscopes-for-minimally-invasive-surgery

More news

All news
News

Pitching at Swissnex Startup Camp in San Francisco

Dexterous Endoscopes was one of 10 Swiss startups selected for the Innosuisse Startup Camp at Swissnex in San Francisco, pitching its variable stiffness endoscope to the Bay Area innovation community.

News

Dexterous Endoscopes named Top100 Swiss Startup Newcomer of the Year 2026

Dexterous Endoscopes won the Newcomer of the Year award, recognising the best newcomer in the Top100 Swiss Startup ranking 2026, at the award night in Zurich.

Fundraising

FIT supports Dexterous Endoscopes with a CHF 100k Tech Seed loan

The Foundation for Innovation and Technology (FIT) has granted Dexterous Endoscopes a CHF 100,000 Tech Seed loan to continue preclinical trials and prepare the regulatory and industrialisation stages of its variable stiffness endoscope.

Fundraising

Our new home: Biopôle, supported by the Biopôle Starting Fund

Dexterous Endoscopes has opened its office at Biopôle in Lausanne and has been awarded CHF 63,000 from the Biopôle Starting Fund.